Business
Why the Polynovo (ASX:PNV) share price up 6% higher today // Motley Fool Australia
The Polynovo Ltd (ASX: PNV) share price is soaring higher today. This comes after the company announced an approval of a pivotal trial investigation device exemption (IDE).
During mid-morning trade, shares in the medical device company reached an intra-day high of $2.98. However, the Polynovo share price has since slightly retreated to $2.97, up 6.07% at the time of writing.
Let’s take a look at what Polynovo updated the market with.
FDA approval for clinical trial
Polynovo advised that the United States Food and Drug Administration (FDA) has approved the pivotal trial IDE for NovoSorb BTM. The authorisation allows Polynovo to begin patient recruitment, once various hospital Independent Review Boards grant approval.
Polynovo will…
-
General22 hours agoUK deputy prime minister Angela Rayner resigns over property tax error
-
Business19 hours agoWall Street analysts say to buy one, but think the other is overvalued
-
General21 hours agoOldest member of British royal family, Katherine, Duchess of Kent, dies aged 92
-
Noosa News13 hours agoBrisbane city acquires 20 hectares of public land through post-floods property buyback scheme